Functional interaction between morphine and central amygdala cannabinoid CB1 receptors in the acquisition and expression of conditioned place preference

Behavioural Brain Research

Volumn 220, Issue 1, 2011, Pages 1-8

  Rezayof, Ameneh ^a   Sardari, Maryam ^a   Zarrindast, Mohammad Reza ^b,c,d,e   Nayer Nouri, Touraj ^b  

^a UNIVERSITY OF TEHRAN   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d INSTITUTE FOR RESEARCH IN FUNDAMENTAL SCIENCES IPM   (Iran)

^e INSTITUTE FOR COGNITIVE SCIENCE STUDIES   (Iran)

Author keywords

ACPA; AM251; Central amygdala; Conditioned place preference; Morphine; Rat(s)

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; ARACHYDONYLCYCLOPROPYLAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR AGONIST; MORPHINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CENTRAL NUCLEUS (AMYGDALA); CONDITIONED PLACE AVERSION; CONTROLLED STUDY; LOCOMOTION; MALE; NONHUMAN; PLACE PREFERENCE; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; TASK PERFORMANCE;

AMYGDALA; ANALYSIS OF VARIANCE; ANIMALS; ARACHIDONIC ACIDS; CONDITIONING, OPERANT; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; MALE; MORPHINE; MOTOR ACTIVITY; NARCOTICS; PIPERIDINES; PYRAZOLES; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; REINFORCEMENT SCHEDULE;

EID: 79751533509     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2011.01.023     Document Type: Article

References (57)

1. Asan E. The catecholaminergic innervation of the rat amygdala. Adv Anat Embryol Cell Biol 1998, 142:1-118.
2. Azizi P., Haghparast A., Hassanpour-Ezatti M. Effects of CB1 receptor antagonist within the nucleus accumbens on the acquisition and expression of morphine-induced conditioned place preference in morphine-sensitized rats. Behav Brain Res 2009, 197:119-124.
3. Bie B., Zhu W., Pan Z.Z. Ethanol-induced delta-opioid receptor modulation of glutamate synaptic transmission and conditioned place preference in central amygdala. Neuroscience 2009, 160:348-358.
4. Braida D., Pozzi M., Cavallini R., Sala M. Conditioned place preference induced by the cannabinoid agonist CP 55,940: interaction with the opioid system. Neuroscience 2001, 104:923-926.
5. Cadoni C., Valentini V., Di Chiara G. Behavioral sensitization to delta 9-tetrahydrocannabinol and cross-sensitization with morphine: differential changes in accumbal shell and core dopamine transmission. J Neurochem 2008, 106:1586-1593.
6. Carlezon WAJr, Thomas M.J. Biological substrates of reward and aversion: a nucleus accumbens activity hypothesis. Neuropharmacology 2009, 56:122-132. Suppl 1.
7. Carr G.D., White N.M. Conditioned place preference from intra-accumbens but not intra-caudate amphetamine injections. Life Sci 1983, 33:2551-2557.
8. Chaperon F., Soubrie P., Puech A.J., Thiebot M.H. Involvement of central cannabinoid (CB1) receptors in the establishment of place conditioning in rats. Psychopharmacology (Berl) 1998, 135:324-332.
9. Chen B.T., Hopf F.W., Bonci A. Synaptic plasticity in the mesolimbic system: therapeutic implications for substance abuse. Ann N Y Acad Sci 2010, 1187:129-139.
10. Egertova M., Elphick M.R. Localization of cannabinoid receptors in the rat brain using antibodies to the intracellular C-terminal tail of CB. J Comp Neurol 2000, 422:159-171.
11. Finn D.P., Beckett S.R., Roe C.H., Madjd A., Fone K.C., Kendall D.A., et al. Effects of coadministration of cannabinoids and morphine on nociceptive behaviour, brain monoamines and HPA axis activity in a rat model of persistent pain. Eur J Neurosci 2004, 19:678-686.
12. Gessa G.L., Melis M., Muntoni A.L., Diana M. Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors. Eur J Pharmacol 1998, 341:39-44.
13. Ghozland S., Matthes H.W., Simonin F., Filliol D., Kieffer B.L., Maldonado R. Motivational effects of cannabinoids are mediated by mu-opioid and kappa-opioid receptors. J Neurosci 2002, 22:1146-1154.
14. Jardinaud F., Roques B.P., Noble F. Tolerance to the reinforcing effects of morphine in delta9-tetrahydrocannabinol treated mice. Behav Brain Res 2006, 173:255-261.
15. Katona I., Rancz E.A., Acsady L., Ledent C., Mackie K., Hajos N., et al. Distribution of CB1 cannabinoid receptors in the amygdala and their role in the control of GABAergic transmission. J Neurosci 2001, 21:9506-9518.
16. Kertes E., Laszlo K., Berta B., Lenard L. Positive reinforcing effects of substance P in the rat central nucleus of amygdala. Behav Brain Res 2009, 205:307-310.
17. Le Foll B., Wiggins M., Goldberg S.R. Nicotine pre-exposure does not potentiate the locomotor or rewarding effects of delta-9-tetrahydrocannabinol in rats. Behav Pharmacol 2006, 17:195-199.
18. Lepore M., Vorel S.R., Lowinson J., Gardner E.L. Conditioned place preference induced by delta 9-tetrahydrocannabinol: comparison with cocaine, morphine, and food reward. Life Sci 1995, 56:2073-2080.
19. López-Moreno J.A., López-Jiménez A., Gorriti M.A., de Fonseca F.R. Functional interactions between endogenous cannabinoid and opioid systems: focus on alcohol, genetics and drug-addicted behaviors. Curr Drug Targets 2010, 11:406-428.
20. Mahler S.V., Berridge K.C. Which cue to "want?" Central amygdala opioid activation enhances and focuses incentive salience on a prepotent reward cue. J Neurosci 2009, 29:6500-6513.
21. Maldonado R. The neurobiology of addiction. J Neural Transm Suppl 2003, 1-14.
22. Manzanares J., Corchero J., Romero J., Fernandez-Ruiz J.J., Ramos J.A., Fuentes J.A. Pharmacological and biochemical interactions between opioids and cannabinoids. Trends Pharmacol Sci 1999, 20:287-294.
23. Manzanedo C., Rodriguez-Arias M., Daza-Losada M., Maldonado C., Aguilar M.A., Minarro J. Effect of the CB1 cannabinoid agonist WIN 55212-2 on the acquisition and reinstatement of MDMA-induced conditioned place preference in mice. Behav Brain Funct 2010, 6-19.
24. Mascia M.S., Obinu M.C., Ledent C., Parmentier M., Bohme G.A., Imperato A., et al. Lack of morphine-induced dopamine release in the nucleus accumbens of cannabinoid CB(1) receptor knockout mice. Eur J Pharmacol 1999, 383:R1-2.
25. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990, 346:561-564.
26. McBride W.J., Murphy J.M., Ikemoto S. Localization of brain reinforcement mechanisms: intracranial self-administration and intracranial place-conditioning studies. Behav Brain Res 1999, 101:129-152.
27. McGregor I.S., Issakidis C.N., Prior G. Aversive effects of the synthetic cannabinoid CP 55,940 in rats. Pharmacol Biochem Behav 1996, 53:657-664.
28. Narita M., Funada M., Suzuki T. Regulations of opioid dependence by opioid receptor types. Pharmacol Ther 2001, 89:1-15.
29. Navarro M., Carrera M.R., Fratta W., Valverde O., Cossu G., Fattore L., et al. Functional interaction between opioid and cannabinoid receptors in drug self-administration. J Neurosci 2001, 21:5344-5350.
30. Pacheco Dda F., Klein A., Perez A.C., Pacheco C.M., de Francischi J.N., Reis G.M., et al. Central antinociception induced by mu-opioid receptor agonist morphine, but not delta or kappa is mediated by cannabinoid CB1 receptor. Br J Pharmacol 2009, 158:225-231.
31. Parolaro D., Rubino T. The role of the endogenous cannabinoid system in drug addiction. Drug News Perspect 2008, 21:149-157.
32. Lopez A., Salome L. Membrane functional organisation and dynamic of mu-opioid receptors. Cell Mol Life Sci 2009, 66:2093-2108.
33. Paxinos G., Watson C. The rat brain in stereotaxic coordinates 2007, Academic Press, San Diego, CA.
34. Pickel V.M., Chan J., Kash T.L., Rodriguez J.J., MacKie K. Compartment-specific localization of cannabinoid 1 (CB1) and mu-opioid receptors in rat nucleus accumbens. Neuroscience 2004, 127:101-112.
35. Polissidis A., Chouliara O., Galanopoulos A., Marselos M., Papadopoulou-Daifoti Z., Antoniou K. Behavioural and dopaminergic alterations induced by a low dose of WIN 55 212-2 in a conditioned place preference procedure. Life Sci 2009, 85:248-254.
36. Pontieri F.E., Monnazzi P., Scontrini A., Buttarelli F.R., Patacchioli F.R. Behavioral sensitization to heroin by cannabinoid pretreatment in the rat. Eur J Pharmacol 2001, 421:R1-3.
37. Rezayof A., Golhasani-Keshtan F., Haeri-Rohani A., Zarrindast M.R. Morphine-induced place preference: involvement of the central amygdala NMDA receptors. Brain Res 2007, 1133:34-41.
38. Rezayof A., Razavi S., Haeri-Rohani A., Rassouli Y., Zarrindast M.R. GABA(A) receptors of hippocampal CA1 regions are involved in the acquisition and expression of morphine-induced place preference. Eur Neuropsychopharmacol 2007, 17:24-31.
39. Rezayof A., Zarrindast M.R., Sahraei H., Haeri-Rohani A. Involvement of dopamine D2 receptors of the central amygdala on the acquisition and expression of morphine-induced place preference in rat. Pharmacol Biochem Behav 2002, 74:187-197.
40. Roberto M., Cruz M., Bajo M., Siggins G.R., Parsons L.H., Schweitzer P. The endocannabinoid system tonically regulates inhibitory transmission and depresses the effect of ethanol in central amygdala. Neuropsychopharmacology 2010, 35:1962-1972.
41. Robledo P., Berrendero F., Ozaita A., Maldonado R. Advances in the field of cannabinoid-opioid cross-talk. Addict Biol 2008, 13:213-224.
42. Rodriguez De Fonseca F., Rubio P., Martin-Calderon J.L., Caine S.B., Koob G.F., Navarro M. The dopamine receptor agonist 7-OH-DPAT modulates the acquisition and expression of morphine-induced place preference. Eur J Pharmacol 1995, 274:47-55.
43. Sanudo-Pena M.C., Tsou K., Delay E.R., Hohman A.G., Force M., Walker J.M. Endogenous cannabinoids as an aversive or counter-rewarding system in the rat. Neurosci Lett 1997, 223:125-128.
44. Solinas M., Goldberg S.R. Involvement of mu-, delta- and kappa-opioid receptor subtypes in the discriminative-stimulus effects of delta-9-tetrahydrocannabinol (THC) in rats. Psychopharmacology (Berl) 2005, 179:804-812.
45. Trang T., Sutak M., Jhamandas K. Involvement of cannabinoid (CB1)-receptors in the development and maintenance of opioid tolerance. Neuroscience 2007, 146:1275-1288.
46. T.M.Tzschentke T. Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade. Addict Biol 2007, 12:227-462.
47. Valjent E., Maldonado R. A behavioural model to reveal place preference to delta 9-tetrahydrocannabinol in mice. Psychopharmacology (Berl) 2000, 147:436-438.
48. Vela G., Fuentes J.A., Bonnin A., Fernandez-Ruiz J., Ruiz-Gayo M. Perinatal exposure to delta 9-tetrahydrocannabinol (delta 9-THC) leads to changes in opioid-related behavioral patterns in rats. Brain Res 1995, 680:142-147.
49. Vetulani J. Drug addiction Part II. Neurobiology of addiction. Pol J Pharmacol 2001, 53:303-317.
50. Vigano D., Valenti M., Cascio M.G., Di Marzo V., Parolaro D., Rubino T. Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine. Eur J Neurosci 2004, 20:1849-1857.
51. Vlachou S., Nomikos G.G., Stephens D.N., Panagis G. Lack of evidence for appetitive effects of delta 9-tetrahydrocannabinol in the intracranial self-stimulation and conditioned place preference procedures in rodents. Behav Pharmacol 2007, 18:311-319.
52. Wallace D.M., Magnuson D.J., Gray T.S. Organization of amygdaloid projections to brainstem dopaminergic, noradrenergic, and adrenergic cell groups in the rat. Brain Res Bull 1992, 28:447-454.
53. Watanabe T., Nakagawa T., Yamamoto R., Maeda A., Minami M., Satoh M. Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats. Jpn J Pharmacol 2002, 88:399-406.
54. Zarrindast M.R., Nouri M., Ahmadi S. Cannabinoid CB1 receptors of the dorsal hippocampus are important for induction of conditioned place preference (CPP) but do not change morphine CPP. Brain Res 2007, 1163:130-137.
55. Zarrindast M.R., Rezayof A., Sahraei H., Haeri-Rohani A., Rassouli Y. Involvement of dopamine D1 receptors of the central amygdala on the acquisition and expression of morphine-induced place preference in rat. Brain Res 2003, 965:212-221.
56. Zarrindast M.R., Sarahroodi S., Arzi A., Khodayar M.J., Taheri-Shalmani S., Rezayof A. Cannabinoid CB1 receptors of the rat central amygdala mediate anxiety-like behavior: interaction with the opioid system. Behav Pharmacol 2008, 19:716-723.
57. Zimmer A., Valjent E., Konig M., Zimmer A.M., Robledo P., Hahn H., et al. Absence of delta-9-tetrahydrocannabinol dysphoric effects in dynorphin-deficient mice. J Neurosci 2001, 21:9499-9505.